Ana Cristina Gimenes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Cristina Gimenes has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Carla Malaguti
Universidade Federal de Juiz de Fora, Brasil
2 shared publications J. Alberto Neder
Division of Respiratory Medicine, Department of Medicine, Pulmonary Function and Clinical Exercise Physiology Unit, Federal University of Sao Paulo, Paulista School of Medicine (UNIFESP-EPM), Sao Paulo, Brazil
2 shared publicationsJ.A. Neder
Setor de Função Pulmonar e Fisiologia Clínica do Exercício, Universidade Federal de São Paulo, São Paulo, SP, Brasil
2 shared publicationsLuiz E. Nery
Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil
2 shared publications- Luiz Eduardo Nery
Universidade Federal de São Paulo
2 shared publications Simone Dal Corso
Federal University of São Paulo Paulista School of Medicine Department of Medicine
2 shared publications
Latest Publications
- Open Access
- 1 May 2021
- Published by International Journal for Innovation Education and Research in International Journal for Innovation Education and Research
- Vol. 9 (5) , 211-217
Anatomical characteristics of the accessory hepatic lobe and its clinical-functional particularities
Riedel's lobe (ectopic lobe), also known as the accessory hepatic lobe, consists of an anatomical variation characterized by a tongue-shaped protrusion on the visceral surface of the liver right lobe, fixed by a pedicle. This variant draws attention in the clinical practice, as it can be mistaken for a tumor due to its elongated aspect. The aim of this research was to conduct a study on the anatomical characteristics and clinical and functional peculiarities of the accessory hepatic lobe. The paper is based on a integrative review and observational study on a cadaveric specimen. A cadaver with anatomical variation was used. Data were collected in PubMed, Scielo, and VHL. 257 articles were found in the databases, but only 13 were used for research. In careful review, two rare cases of the accessory lobe in the left lobe of the liver, hypoplastic left lobes, and agenesis of the right hepatic lobe, and often the clinical picture without changes in signs and symptoms were found. These morphological abnormalities' clinical impact is limited in the absence of underlying liver disease, cirrhosis, or known cancer. In case of complications or after the diagnosis of pedunculated tumors in the liver, laparoscopy is well indicated for removing these lobes or tumors.
- 1 May 2021
- Published by International Journal for Innovation Education and Research in International Journal for Innovation Education and Research
- Vol. 9 (5) , 211-217
Open AccessAnatomical characteristics of the accessory hepatic lobe and its clinical-functional particularities
Riedel's lobe (ectopic lobe), also known as the accessory hepatic lobe, consists of an anatomical variation characterized by a tongue-shaped protrusion on the visceral surface of the liver right lobe, fixed by a pedicle. This variant draws attention in the clinical practice, as it can be mistaken for a tumor due to its elongated aspect. The aim of this research was to conduct a study on the anatomical characteristics and clinical and functional peculiarities of the accessory hepatic lobe. The paper is based on a integrative review and observational study on a cadaveric specimen. A cadaver with anatomical variation was used. Data were collected in PubMed, Scielo, and VHL. 257 articles were found in the databases, but only 13 were used for research. In careful review, two rare cases of the accessory lobe in the left lobe of the liver, hypoplastic left lobes, and agenesis of the right hepatic lobe, and often the clinical picture without changes in signs and symptoms were found. These morphological abnormalities' clinical impact is limited in the absence of underlying liver disease, cirrhosis, or known cancer. In case of complications or after the diagnosis of pedunculated tumors in the liver, laparoscopy is well indicated for removing these lobes or tumors.
- 1 April 2018
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 250, 7-13
Excess ventilation in COPD: Implications for dyspnoea and tolerance to interval exercise
- 1 April 2018
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 250, 7-13
Excess ventilation in COPD: Implications for dyspnoea and tolerance to interval exercise
- 28 July 2016
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 116 (10) , 1899-1910
High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients
It was hypothesized that patients with chronic obstructive pulmonary disease (COPD) would exhibit a slow muscle deoxygenation (HHb) recovery time when compared with sedentary controls. Neuromuscular electrical stimulation (NMES 40 and 50 mA, 50 Hz, 400 µs) was employed to induce isometric contraction of the quadriceps. Microvascular oxygen extraction (µO2EF) and HHb were estimated by near-infrared spectroscopy (NIRS). Recovery kinetic was characterized by measuring the time constant Tau (HHb-τ). Torque and work were measured by isokinetic dynamometry in 13 non-hypoxaemic patients with moderate-to-severe COPD [SpO2 = 94.1 ± 1.6 %; FEV1 (% predict) 48.0 ± 9.6; GOLD II–III] and 13 age- and sex-matched sedentary controls. There was no desaturation in either group during NMES. Torque and work were reduced in COPD versus control for 40 and 50 mA [torque (Nm) 50 mA = 28.9 ± 6.9 vs 46.1 ± 14.2; work (J) 50 mA = 437.2 ± 130.0 vs. 608.3 ± 136.8; P < 0.05 for all]. High µO2EF values were observed in the COPD group at both NMES intensities (corrected by muscle mass 50 mA = 6.18 ± 1.1 vs. 4.68 ± 1.0 %/kg; corrected by work 50 mA = 0.12 ± 0.05 vs. 0.07 ± 0.02 %/J; P < 0.05 for all). Absolute values of HHb-τ (50 mA = 31.11 ± 9.27 vs. 18.08 ± 10.70 s), corrected for muscle mass (50 mA 3.80 ± 1.28 vs. 2.05 ± 1.45 s/kg) and corrected for work (50 mA = 0.08 ± 0.04 vs. 0.03 ± 0.02 s/J) were reduced in COPD (P < 0.05 for all). The variables behaviour for 40 mA was similar to those of 50 mA. COPD patients exhibited a slower muscle deoxygenation recovery time after NMES. The absence of desaturation, low torque and work, high µO2EF and high values for recovery time corrected by muscle mass and work suggest that intrinsic muscle dysfunction has an impact on muscle recovery capacity.
- 28 July 2016
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 116 (10) , 1899-1910
High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients
It was hypothesized that patients with chronic obstructive pulmonary disease (COPD) would exhibit a slow muscle deoxygenation (HHb) recovery time when compared with sedentary controls. Neuromuscular electrical stimulation (NMES 40 and 50 mA, 50 Hz, 400 µs) was employed to induce isometric contraction of the quadriceps. Microvascular oxygen extraction (µO2EF) and HHb were estimated by near-infrared spectroscopy (NIRS). Recovery kinetic was characterized by measuring the time constant Tau (HHb-τ). Torque and work were measured by isokinetic dynamometry in 13 non-hypoxaemic patients with moderate-to-severe COPD [SpO2 = 94.1 ± 1.6 %; FEV1 (% predict) 48.0 ± 9.6; GOLD II–III] and 13 age- and sex-matched sedentary controls. There was no desaturation in either group during NMES. Torque and work were reduced in COPD versus control for 40 and 50 mA [torque (Nm) 50 mA = 28.9 ± 6.9 vs 46.1 ± 14.2; work (J) 50 mA = 437.2 ± 130.0 vs. 608.3 ± 136.8; P < 0.05 for all]. High µO2EF values were observed in the COPD group at both NMES intensities (corrected by muscle mass 50 mA = 6.18 ± 1.1 vs. 4.68 ± 1.0 %/kg; corrected by work 50 mA = 0.12 ± 0.05 vs. 0.07 ± 0.02 %/J; P < 0.05 for all). Absolute values of HHb-τ (50 mA = 31.11 ± 9.27 vs. 18.08 ± 10.70 s), corrected for muscle mass (50 mA 3.80 ± 1.28 vs. 2.05 ± 1.45 s/kg) and corrected for work (50 mA = 0.08 ± 0.04 vs. 0.03 ± 0.02 s/J) were reduced in COPD (P < 0.05 for all). The variables behaviour for 40 mA was similar to those of 50 mA. COPD patients exhibited a slower muscle deoxygenation recovery time after NMES. The absence of desaturation, low torque and work, high µO2EF and high values for recovery time corrected by muscle mass and work suggest that intrinsic muscle dysfunction has an impact on muscle recovery capacity.
- Open Access
- 19 December 2015
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 11 (1) , 1-6
Influence of heat and moisture exchanger use on measurements performed with manovacuometer and respirometer in healthy adults
The use of evaluation tools such as the manovacuometer and respirometer is frequent and disinfection is usually limited to the external surfaces, which is insufficient and raises concerns because of the potential spread of infectious diseases. Hydrophobic heat and moisture exchangers (HME) are used in mechanical ventilation and have microbiological filters, which can possibly reduce contamination, increasing the safety of related procedures. It is unknown, however, if the addition of an exchanger affects the measurements obtained. Aim of this study was to verify if the use of an HME interferes in maximal inspiratory and expiratory pressures assessed using the manovacuometer and vital capacity evaluated using the respirometer in healthy adults. A controlled transversal trial was carried out. Twenty healthy young adults were included in the study. Vital capacity by respirometer and, maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were assessed with and without the use of HME. No significant difference was found between the values pre and post HME use in vital capacity measurements: (3878.8 ± 202.2 mL vs. 3925.5 ± 206.0 mL, p = 0.116) and the respiratory muscle strength measurements: MIP (−99.0 ± 8.9 vs −95.5 ± 9.0 cm H2O, p = 0.149) and MEP (92.5 ± 7.5 vs 92.5 ± 7.7 cm H2O, p = 1.0) respectively. We conclude that the use of HME does not modify the lung volumes or respiratory muscle strength, and can be used in order to reduce the occurrence of pulmonary infection.
- 19 December 2015
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 11 (1) , 1-6
Open AccessInfluence of heat and moisture exchanger use on measurements performed with manovacuometer and respirometer in healthy adults
The use of evaluation tools such as the manovacuometer and respirometer is frequent and disinfection is usually limited to the external surfaces, which is insufficient and raises concerns because of the potential spread of infectious diseases. Hydrophobic heat and moisture exchangers (HME) are used in mechanical ventilation and have microbiological filters, which can possibly reduce contamination, increasing the safety of related procedures. It is unknown, however, if the addition of an exchanger affects the measurements obtained. Aim of this study was to verify if the use of an HME interferes in maximal inspiratory and expiratory pressures assessed using the manovacuometer and vital capacity evaluated using the respirometer in healthy adults. A controlled transversal trial was carried out. Twenty healthy young adults were included in the study. Vital capacity by respirometer and, maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were assessed with and without the use of HME. No significant difference was found between the values pre and post HME use in vital capacity measurements: (3878.8 ± 202.2 mL vs. 3925.5 ± 206.0 mL, p = 0.116) and the respiratory muscle strength measurements: MIP (−99.0 ± 8.9 vs −95.5 ± 9.0 cm H2O, p = 0.149) and MEP (92.5 ± 7.5 vs 92.5 ± 7.7 cm H2O, p = 1.0) respectively. We conclude that the use of HME does not modify the lung volumes or respiratory muscle strength, and can be used in order to reduce the occurrence of pulmonary infection.
- Open Access
- 1 April 2015
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 48 (4) , 354-362
Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy
Exercise intolerance due to impaired oxidative metabolism is a prominent symptom in patients with mitochondrial myopathy (MM), but it is still uncertain whether L-carnitine supplementation is beneficial for patients with MM. The aim of our study was to investigate the effects of L-carnitine on exercise performance in MM. Twelve MM subjects (mean age±SD=35.4±10.8 years) with chronic progressive external ophthalmoplegia (CPEO) were first compared to 10 healthy controls (mean age±SD=29±7.8 years) before they were randomly assigned to receive L-carnitine supplementation (3 g/daily) or placebo in a double-blind crossover design. Clinical status, body composition, respiratory function tests, peripheral muscle strength (isokinetic and isometric torque) and cardiopulmonary exercise tests (incremental to peak exercise and at 70% of maximal), constant work rate (CWR) exercise test, to the limit of tolerance [Tlim]) were assessed after 2 months of L-carnitine/placebo administration. Patients with MM presented with lower mean height, total body weight, fat-free mass, and peripheral muscle strength compared to controls in the pre-test evaluation. After L-carnitine supplementation, the patients with MM significantly improved their Tlim (14±1.9 vs 11±1.4 min) and oxygen consumption ( ) at CWR exercise, both at isotime (1151±115 vs 1049±104 mL/min) and at Tlim (1223±114 vs 1060±108 mL/min). These results indicate that L-carnitine supplementation may improve aerobic capacity and exercise tolerance during high-intensity CWRs in MM patients with CPEO.- 1 April 2015
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 48 (4) , 354-362
Open AccessEffect of L-carnitine on exercise performance in patients with mitochondrial myopathy
Exercise intolerance due to impaired oxidative metabolism is a prominent symptom in patients with mitochondrial myopathy (MM), but it is still uncertain whether L-carnitine supplementation is beneficial for patients with MM. The aim of our study was to investigate the effects of L-carnitine on exercise performance in MM. Twelve MM subjects (mean age±SD=35.4±10.8 years) with chronic progressive external ophthalmoplegia (CPEO) were first compared to 10 healthy controls (mean age±SD=29±7.8 years) before they were randomly assigned to receive L-carnitine supplementation (3 g/daily) or placebo in a double-blind crossover design. Clinical status, body composition, respiratory function tests, peripheral muscle strength (isokinetic and isometric torque) and cardiopulmonary exercise tests (incremental to peak exercise and at 70% of maximal), constant work rate (CWR) exercise test, to the limit of tolerance [Tlim]) were assessed after 2 months of L-carnitine/placebo administration. Patients with MM presented with lower mean height, total body weight, fat-free mass, and peripheral muscle strength compared to controls in the pre-test evaluation. After L-carnitine supplementation, the patients with MM significantly improved their Tlim (14±1.9 vs 11±1.4 min) and oxygen consumption ( ) at CWR exercise, both at isotime (1151±115 vs 1049±104 mL/min) and at Tlim (1223±114 vs 1060±108 mL/min). These results indicate that L-carnitine supplementation may improve aerobic capacity and exercise tolerance during high-intensity CWRs in MM patients with CPEO. - 19 August 2013
- Published by Wiley in Pediatric Pulmonology
- Vol. 49 (3) , 238-244
Effects of inspiratory muscle training on lung volumes, respiratory muscle strength, and quality of life in patients with ataxia telangiectasia
Summary: Background: Ataxia telangiectasia (AT) is a genetic syndrome caused by a mutation of chromosome 11. The clinical features are cerebellar ataxia, telangiectasia, and progressive loss of muscular coordination, including an inefficient cough secondary to progression of neurological disease.Objective: To evaluate the effects of inspiratory muscle training (IMT) on ventilation, lung volume, dyspnoea, respiratory muscle strength, and quality of life in patients with AT.Methods: A longitudinal study was conducted with 11 AT patients and nine healthy volunteers. Ventilometry, subjective sensation of dyspnoea, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), and quality of life were assessed before and after a 24‐week IMT program. The IMT load used was set at 60% of the MIP, and the training was performed for 20 min daily.Results: Patients with AT had lower height and weight and also had lower respiratory muscle strength and lung volume compared with healthy volunteers. Furthermore, patients with AT showed a significant improvement when pre‐ and post‐IMT were compared for ventilatory pattern: Vt (476.5 ± 135 ml vs. 583.3 ± 66 ml, P = 0.015) and f (23.3 ± 6 rpm vs. 20.4 ± 4 rpm, P = 0.018), and VC (1,664 ± 463 ml/kg vs. 2,145 ± 750 ml/kg, P = 0.002). IMT also significantly improved the sensation of dyspnoea (median 0.5; minimum 0; maximum 1.0; P = 0.022) and respiratory muscle strength: MIP (−22.2 ± 2 cmH2O vs. −38 ± 9 cmH2O, P < 0.001) and MEP (29 ± 7 cmH2O vs. 40 ± 8 cmH2O, P = 0.001). The health and vitality domains of the SF‐36 also showed significant improvement (P = 0.009 and P = 0.014, respectively) post‐IMT.Conclusion: IMT was effective in improving ventilatory pattern, lung volume, respiratory muscle strength, and the health and vitality domains for quality of life in patients with AT. IMT may be an effective adjunct therapy to drug treatment for patients with AT. Pediatr Pulmonol. 2014; 49:238–244.
- 19 August 2013
- Published by Wiley in Pediatric Pulmonology
- Vol. 49 (3) , 238-244
Effects of inspiratory muscle training on lung volumes, respiratory muscle strength, and quality of life in patients with ataxia telangiectasia
Summary: Background: Ataxia telangiectasia (AT) is a genetic syndrome caused by a mutation of chromosome 11. The clinical features are cerebellar ataxia, telangiectasia, and progressive loss of muscular coordination, including an inefficient cough secondary to progression of neurological disease.Objective: To evaluate the effects of inspiratory muscle training (IMT) on ventilation, lung volume, dyspnoea, respiratory muscle strength, and quality of life in patients with AT.Methods: A longitudinal study was conducted with 11 AT patients and nine healthy volunteers. Ventilometry, subjective sensation of dyspnoea, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), and quality of life were assessed before and after a 24‐week IMT program. The IMT load used was set at 60% of the MIP, and the training was performed for 20 min daily.Results: Patients with AT had lower height and weight and also had lower respiratory muscle strength and lung volume compared with healthy volunteers. Furthermore, patients with AT showed a significant improvement when pre‐ and post‐IMT were compared for ventilatory pattern: Vt (476.5 ± 135 ml vs. 583.3 ± 66 ml, P = 0.015) and f (23.3 ± 6 rpm vs. 20.4 ± 4 rpm, P = 0.018), and VC (1,664 ± 463 ml/kg vs. 2,145 ± 750 ml/kg, P = 0.002). IMT also significantly improved the sensation of dyspnoea (median 0.5; minimum 0; maximum 1.0; P = 0.022) and respiratory muscle strength: MIP (−22.2 ± 2 cmH2O vs. −38 ± 9 cmH2O, P < 0.001) and MEP (29 ± 7 cmH2O vs. 40 ± 8 cmH2O, P = 0.001). The health and vitality domains of the SF‐36 also showed significant improvement (P = 0.009 and P = 0.014, respectively) post‐IMT.Conclusion: IMT was effective in improving ventilatory pattern, lung volume, respiratory muscle strength, and the health and vitality domains for quality of life in patients with AT. IMT may be an effective adjunct therapy to drug treatment for patients with AT. Pediatr Pulmonol. 2014; 49:238–244.
- 4 September 2011
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 112 (5) , 1763-1771
Skeletal muscle reoxygenation after high-intensity exercise in mitochondrial myopathy
This study addressed whether O2 delivery during recovery from high-intensity, supra-gas exchange threshold exercise would be matched to O2 utilization at the microvascular level in patients with mitochondrial myopathy (MM). Off-exercise kinetics of (1) pulmonary O2 uptake \( (\dot{V}{\text{O}}_{2} {\text{p}}), \) (2) an index of fractional O2 extraction by near-infrared spectroscopy (Δ[deoxy-Hb + Mb]) in the vastus lateralis and (3) cardiac output (Q ′T ) by impedance cardiography were assessed in 12 patients with biopsy-proven MM (chronic progressive external ophthalmoplegia) and 12 age- and gender-matched controls. Kinetics of \( \dot{V}{\text{O}}_{2} {\text{p}} \) were significantly slower in patients than controls (τ = 53.8 ± 16.5 vs. 38.8 ± 7.6 s, respectively; p < 0.05). Q ′T , however, declined at similar rates (τ = 64.7 ± 18.8 vs. 73.0 ± 21.6 s; p > 0.05) being typically slower than \( \dot{V}{\text{O}}_{2} {\text{p}} \) in both groups. Importantly, Δ[deoxy-Hb + Mb] dynamics (MRT) were equal to, or faster than, \( \tau \dot{V}{\text{O}}_{2} {\text{p}} \) in patients and controls, respectively. In fact, there were no between-group differences in \( \tau \dot{V}{\text{O}}_{2} {\text{p}} \)/MRTΔ[deoxy-Hb + Mb] (1.1 ± 0.4 vs. 1.0 ± 0.2, p > 0.05) thereby indicating similar rates of microvascular O2 delivery. These data indicate that the slower rate of recovery of muscle metabolism after high-intensity exercise is not related to impaired microvascular O2 delivery in patients with MM. This phenomenon, therefore, seems to reflect the intra-myocyte abnormalities that characterize this patient population.- 4 September 2011
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 112 (5) , 1763-1771
Skeletal muscle reoxygenation after high-intensity exercise in mitochondrial myopathy
This study addressed whether O2 delivery during recovery from high-intensity, supra-gas exchange threshold exercise would be matched to O2 utilization at the microvascular level in patients with mitochondrial myopathy (MM). Off-exercise kinetics of (1) pulmonary O2 uptake \( (\dot{V}{\text{O}}_{2} {\text{p}}), \) (2) an index of fractional O2 extraction by near-infrared spectroscopy (Δ[deoxy-Hb + Mb]) in the vastus lateralis and (3) cardiac output (Q ′T ) by impedance cardiography were assessed in 12 patients with biopsy-proven MM (chronic progressive external ophthalmoplegia) and 12 age- and gender-matched controls. Kinetics of \( \dot{V}{\text{O}}_{2} {\text{p}} \) were significantly slower in patients than controls (τ = 53.8 ± 16.5 vs. 38.8 ± 7.6 s, respectively; p < 0.05). Q ′T , however, declined at similar rates (τ = 64.7 ± 18.8 vs. 73.0 ± 21.6 s; p > 0.05) being typically slower than \( \dot{V}{\text{O}}_{2} {\text{p}} \) in both groups. Importantly, Δ[deoxy-Hb + Mb] dynamics (MRT) were equal to, or faster than, \( \tau \dot{V}{\text{O}}_{2} {\text{p}} \) in patients and controls, respectively. In fact, there were no between-group differences in \( \tau \dot{V}{\text{O}}_{2} {\text{p}} \)/MRTΔ[deoxy-Hb + Mb] (1.1 ± 0.4 vs. 1.0 ± 0.2, p > 0.05) thereby indicating similar rates of microvascular O2 delivery. These data indicate that the slower rate of recovery of muscle metabolism after high-intensity exercise is not related to impaired microvascular O2 delivery in patients with MM. This phenomenon, therefore, seems to reflect the intra-myocyte abnormalities that characterize this patient population.- Open Access
- 1 April 2011
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 44 (4) , 354-360
Relationship between work rate and oxygen uptake in mitochondrial myopathy during ramp-incremental exercise
We determined the response characteristics and functional correlates of the dynamic relationship between the rate (Delta) of oxygen consumption ((V)over dotO(2)) and the applied power output (work rate = WR) during ramp-incremental exercise in patients with mitochondrial myopathy (MM). Fourteen patients (7 males, age 35.4 +/- 10.8 years) with biopsy-proven MM and 10 sedentary controls (6 males, age 29.0 +/- 7.8 years) took a ramp-incremental cycle ergometer test for the determination of the (V)over dotO(2) on-exercise mean response time (MRT) and the gas exchange threshold (GET). The Delta(V)over dotO(2)/Delta WR slope was calculated up to GET (S-1), above GET (S-2) and over the entire linear portion of the response (S-T). Knee muscle endurance was measured by isokinetic dynamometry. As expected, peak (V)over dotO(2) and muscle performance were lower in patients than controls (P < 0.05). Patients had significantly lower Delta(V)over dotO(2)/Delta WR than controls, especially the S-2 component (6.8 +/- 1.5 vs 10.3 +/- 0.6 mL.min(-1).W-1, respectively; P < 0.001). There were significant relationships between Delta(V)over dotO(2)/Delta WR (ST) and muscle endurance, MRT-(V)over dotO(2), GET and peak (V)over dotO(2) in MM patients (P < 0.05). In fact, all patients with Delta(V)over dotO(2)/Delta WR below 8 mL.min(-1).W-1 had severely reduced peak (V)over dotO(2) values (< 60% predicted). Moreover, patients with higher cardiopulmonary stresses during exercise (e. g., higher Delta ventilation/carbon dioxide output and Delta heart rate/Delta(V)over dotO(2)) had lower Delta(V)over dotO(2)/Delta WR (P < 0.05). In conclusion, a readily available, effort-independent index of aerobic dysfunction during dynamic exercise (Delta(V)over dotO(2)/Delta WR) is typically reduced in patients with MM, being related to increased functional impairment and higher cardiopulmonary stress.
- 1 April 2011
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 44 (4) , 354-360
Open AccessRelationship between work rate and oxygen uptake in mitochondrial myopathy during ramp-incremental exercise
We determined the response characteristics and functional correlates of the dynamic relationship between the rate (Delta) of oxygen consumption ((V)over dotO(2)) and the applied power output (work rate = WR) during ramp-incremental exercise in patients with mitochondrial myopathy (MM). Fourteen patients (7 males, age 35.4 +/- 10.8 years) with biopsy-proven MM and 10 sedentary controls (6 males, age 29.0 +/- 7.8 years) took a ramp-incremental cycle ergometer test for the determination of the (V)over dotO(2) on-exercise mean response time (MRT) and the gas exchange threshold (GET). The Delta(V)over dotO(2)/Delta WR slope was calculated up to GET (S-1), above GET (S-2) and over the entire linear portion of the response (S-T). Knee muscle endurance was measured by isokinetic dynamometry. As expected, peak (V)over dotO(2) and muscle performance were lower in patients than controls (P < 0.05). Patients had significantly lower Delta(V)over dotO(2)/Delta WR than controls, especially the S-2 component (6.8 +/- 1.5 vs 10.3 +/- 0.6 mL.min(-1).W-1, respectively; P < 0.001). There were significant relationships between Delta(V)over dotO(2)/Delta WR (ST) and muscle endurance, MRT-(V)over dotO(2), GET and peak (V)over dotO(2) in MM patients (P < 0.05). In fact, all patients with Delta(V)over dotO(2)/Delta WR below 8 mL.min(-1).W-1 had severely reduced peak (V)over dotO(2) values (< 60% predicted). Moreover, patients with higher cardiopulmonary stresses during exercise (e. g., higher Delta ventilation/carbon dioxide output and Delta heart rate/Delta(V)over dotO(2)) had lower Delta(V)over dotO(2)/Delta WR (P < 0.05). In conclusion, a readily available, effort-independent index of aerobic dysfunction during dynamic exercise (Delta(V)over dotO(2)/Delta WR) is typically reduced in patients with MM, being related to increased functional impairment and higher cardiopulmonary stress.
- 1 May 2008
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 104 (5) , 1341-1350
Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics
Patients with chronic obstructive pulmonary disease (COPD) have slowed pulmonary O2uptake (V̇o2p) kinetics during exercise, which may stem from inadequate muscle O2delivery. However, it is currently unknown how COPD impacts the dynamic relationship between systemic and microvascular O2delivery to uptake during exercise. We tested the hypothesis that, along with slowed V̇o2pkinetics, COPD patients have faster dynamics of muscle deoxygenation, but slower kinetics of cardiac output (Q̇t) following the onset of heavy-intensity exercise. We measured V̇o2p, Q̇t (impedance cardiography), and muscle deoxygenation (near-infrared spectroscopy) during heavy-intensity exercise performed to the limit of tolerance by 10 patients with moderate-to-severe COPD and 11 age-matched sedentary controls. Variables were analyzed by standard nonlinear regression equations. Time to exercise intolerance was significantly ( P < 0.05) lower in patients and related to the kinetics of V̇o2p( r = −0.70; P < 0.05). Compared with controls, COPD patients displayed slower kinetics of V̇o2p(42 ± 13 vs. 73 ± 24 s) and Q̇t (67 ± 11 vs. 96 ± 32 s), and faster overall kinetics of muscle deoxy-Hb (19.9 ± 2.4 vs. 16.5 ± 3.4 s). Consequently, the time constant ratio of O2uptake to mean response time of deoxy-Hb concentration was significantly greater in patients, suggesting a slower kinetics of microvascular O2delivery. In conclusion, our data show that patients with moderate-to-severe COPD have impaired central and peripheral cardiovascular adjustments following the onset of heavy-intensity exercise. These cardiocirculatory disturbances negatively impact the dynamic matching of O2delivery and utilization and may contribute to the slower V̇o2pkinetics compared with age-matched controls.
- 1 May 2008
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 104 (5) , 1341-1350
Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics
Patients with chronic obstructive pulmonary disease (COPD) have slowed pulmonary O2uptake (V̇o2p) kinetics during exercise, which may stem from inadequate muscle O2delivery. However, it is currently unknown how COPD impacts the dynamic relationship between systemic and microvascular O2delivery to uptake during exercise. We tested the hypothesis that, along with slowed V̇o2pkinetics, COPD patients have faster dynamics of muscle deoxygenation, but slower kinetics of cardiac output (Q̇t) following the onset of heavy-intensity exercise. We measured V̇o2p, Q̇t (impedance cardiography), and muscle deoxygenation (near-infrared spectroscopy) during heavy-intensity exercise performed to the limit of tolerance by 10 patients with moderate-to-severe COPD and 11 age-matched sedentary controls. Variables were analyzed by standard nonlinear regression equations. Time to exercise intolerance was significantly ( P < 0.05) lower in patients and related to the kinetics of V̇o2p( r = −0.70; P < 0.05). Compared with controls, COPD patients displayed slower kinetics of V̇o2p(42 ± 13 vs. 73 ± 24 s) and Q̇t (67 ± 11 vs. 96 ± 32 s), and faster overall kinetics of muscle deoxy-Hb (19.9 ± 2.4 vs. 16.5 ± 3.4 s). Consequently, the time constant ratio of O2uptake to mean response time of deoxy-Hb concentration was significantly greater in patients, suggesting a slower kinetics of microvascular O2delivery. In conclusion, our data show that patients with moderate-to-severe COPD have impaired central and peripheral cardiovascular adjustments following the onset of heavy-intensity exercise. These cardiocirculatory disturbances negatively impact the dynamic matching of O2delivery and utilization and may contribute to the slower V̇o2pkinetics compared with age-matched controls.